United States Federal Circuit

ResetAA Font size: Print

Eli Lily and Co. v. Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Ctr., 2016-1547

In an appeal of inter partes review of the claims of a pharaceutical patent for anticipation by prior art, the Patent Trial and Appeal Board's decision that the prior art did not anticipate the patent's claims by a preponderance of the evidence is affirmed where substantial evidence supports the Board's finding that the prior art does not disclose the claimed treatment regimen with sufficient clarity to satisfy the demanding standard for anticipation.

Appellate Information

  • Argued
  • Submitted
  • Decided
  • Published 2017/02/28




  • United States Federal Circuit


FindLaw Career Center

      Post a Job  |  View More Jobs

    View More